This Week in Hearing

Where do the best ideas in hearing aid innovation come from, and how do they reach patients? In this conversation, Dr. Jason Galster, Vice President of Clinical Research at Sonova, explains how hearing aid research moves from early feasibility to clinical readiness and post-market studies. He discusses how research ideas originate—from clinicians, academic partners, and internal technology roadmaps—and how Sonova

Widex has expanded its Allure™ hearing aid platform with new form factors and charging options, giving hearing care professionals more flexibility across a wider range of patient needs. In this discussion, Dana Helmink, Au.D., Senior Director of Clinical Development at WSA, walks through the addition of a rechargeable Allure BTE, Widex’s first rechargeable ITE, and a new portable charger for

A fully implantable cochlear implant isn’t just a technical milestone—it’s a fundamentally different way of living with hearing loss. In a candid conversation, Gael Hannan speaks with Michael Seufer, one of the first recipients of the Envoy Medical Acclaim, an investigational fully implanted cochlear implant that eliminates external hardware. Michael shares how his hearing loss, first identified in childhood, shaped

A growing number of people are exploring hearing help earlier, and LXE Hearing believes there is a place for devices that bridge the gap between everyday earbuds and traditional hearing aids. In a detailed discussion, LXE Chief Commercial Officer Brian Maguire explains how the newly formed company—created from the merger of Lexie, hearX, and Eargo—is blending strong hardware engineering with

Can lost hearing cells be replaced? Lineage Cell Therapeutics CEO Brian Culley returns to discuss the company’s new collaboration with William Demant Invest. Together, they’re advancing ReSonance™ (ANP1) — an experimental cell therapy designed to replace damaged auditory neurons and potentially restore communication between the ear and the brain. Culley explains how the partnership combines Lineage’s regenerative cell technology with

Hearing loss stigma continues to be one of the biggest barriers to seeking help — even as awareness and technology improve. In this discussion, host Shari Eberts speaks with Dr. Katie Ekberg (Flinders University) and Dr. Louise Hickson (University of Queensland) about their research on hearing loss stigma — exploring how social perceptions, disclosure dilemmas, and outdated stereotypes affect help-seeking

At EUHA 2025, Phonak highlighted the technology behind Infinio Ultra, including insights into the platform’s upgraded AI sound processing, energy efficiency, and new maintenance design. In a discussion at the Phonak booth, Gareth Griffiths, Director of Campaign Management, shared how the updates strengthen Phonak’s focus on real-world hearing performance—delivering clearer speech, simplified care, and longer-lasting reliability for everyday users. The

At EUHA 2025, Oticon introduced its newest in-the-ear hearing aid, Oticon Zeal, bringing the company’s second-generation AI sound processing and BrainHearing™ technology to a smaller, ready-to-fit form factor. In a discussion at the conference, Anja Nagel L’Harraki, Senior Vice President of Global Marketing at Demant, and Ole Asboe Jørgensen, President, Hearing Instrument Group, described Zeal as offering the same audiological

Earlier this month, Starkey released its Omega AI hearing aid platform, and at EUHA 2025, Chief Technology Officer Achin Bhowmik discussed how the company’s latest generation builds on prior AI-driven models with new neural-network architecture designed to improve both hearing performance and health monitoring. Omega AI introduces what Starkey describes as the industry’s first use of three deep neural networks

Early detection of hearing loss shouldn’t stop at birth. In this episode, Dr. Bob Traynor speaks with Dr. James W. Hall III, an internationally recognized audiologist, educator, and author with more than 40 years of experience in clinical and academic audiology. Together, they discuss a new evidence-based approach to preschool and early school-age hearing screening that goes beyond traditional pure